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ABSTRACT
INTRODUCTION
Glimepiride is an antidiabetic agent used for lowering blood glucose levels. It induces the activity of peroxisome proliferator-activated 
receptor-gamma (PPAR gamma). It lowers blood glucose levels by binding to ATP-sensitive potassium channel receptors on the 
surface of pancreatic cells. The purpose of this study was to perform a comparative analysis of different physicochemical parameters 
(weight variation, hardness, thickness, friability, disintegration time, and dissolution time) of 3 different commercially available brands 
of glimepiride in the market. Statistical analysis revealed minor variations in the results. It was found that GETRYL showed the highest 
% dissolution among all the 3 brands whereas AMARYL took the least time to disintegrate. According to the results of the friability test, 
DIABOLD showed the highest stability in the friabilator. However, all 3 brands complied with the official pharmacopoeial limits. The 
quality of the drug largely influences its therapeutic activity. Hence, owing to the similar physicochemical profile, all the 3 brands can 
be interchangeably used. 
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Excessive levels of sugar in the blood leads to a disease 
called Diabetes Mellitus [1]. In a disease-free state, 
energy to the body is provided by utilizing glucose which 
is generally achieved from food intake [2]. The utilization 
of glucose is mediated by the hormone “insulin” 
produced by the beta cells of the pancreas. Insulin is 
released in response to the elevated levels of glucose in 
the body. If the body is unable to secrete insulin or 
insulin is not properly utilizing glucose to produce 
energy, the glucose starts to accumulate in the blood 
and eventually manifests as Diabetes Mellitus. Drugs 
that mimic the secretion or improve the uptake of insulin 
are the preferred choice for type II Diabetes, while, 
insulin and its analogs are the preferred therapeutic 
option in type I. Glimepiride is a frequently used
anti-diabetic agent [3].
GLIMEPIRIDE
Glimepiride belongs to the third generation of sulfonylurea 
which is anti-diabetic agents. Glimepiride is preferred orally 
for patients with type 2 diabetes. It works by lowering the 
body's blood glucose level by promoting the release of 
insulin from beta cells of the pancreas [4]. It has a longer 
duration of action compared to other sulfonylureas and
is metabolized by CYP2C9.  Moreover, it also enhances 
the activity of peroxisome proliferator-activated receptor-
gamma (PPARgamma) [5].
It lowers blood glucose level by binding to the ATP-
sensitive potassium channel receptors in the pancreatic 
cells thus, decreasing the conduction of potassium and 
causing depolarization of the membrane. Depolarization 
of the membrane causes the promotion of calcium ion 
influx through voltage-gated calcium channels. This in 
turn causes an increase of intracellular calcium ion 
concentration which ultimately induces the secretion of 
insulin [6] as illustrated in Fig. (1). The drug therapy is 
usually initiated at 1-2 mg.
The purpose of the present investigation was to
compare different physicochemical parameters (weight 
variation, hardness, thickness, friability, disintegration 
time, and dissolution time) of 3 different brands of
glimepiride commonly available in the market.
MATERIALS AND METHODS
A comparative physicochemical study was carried out 
by purchasing 3 different brands of glimepiride (1mg) 
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Fig. (1): Mechanism of action of Glimepiride.
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tablet, namely Diabold, Amaryl, and Getryl available in 
the market (Table 1). The study had been conducted in 
January 2020 and all the experiments were performed in 
the Research Laboratory, Faculty of Pharmacy, Jinnah 
University for Women. The following parameters were 
tested to perform comparative analysis.
1. Weight Variation Test: 20 tablets of each brand 
were weighed using Electronic balance FX-400. They 
were observed for variation in their weight in comparison 
to the standard given by BP/USP which states that NMT 
2 tablets out of 20 tablets should cross ± 10% deviation 
[7]. The test is important to ensure the uniformity of the 
dosage form. The upper control limit and lower control 
limit was also calculated by the following formula:
For upper control limit = Mean + 3x standard deviation
For lower control limit = Mean – 3x standard deviation
2. Thickness Test: It is the degree of compaction. 10 
tablets of each brand were analyzed for their thickness 
by using Vernier Calliper [8].
3. Hardness Test: Hardness refers to the crushing 
strength. We calculated the hardness of 10 tablets of 
each brand by using MH-1 of Galvano Scientific
hardness tester. It works by applying mechanical stress 
to compute the strength of the tablet. The tablet must be 
hard enough to bear the stress of NLT 4kg [9].
4. Friability Test: Tablet tends to chip ultimately
effecting the elegance and appearance of the tablet. 
Besides, content uniformity as well as weight variation is 
also affected. 10 tablets of each brand were taken and 
analyzed on a friabilator at 25 rpm or 100 rotations in
4 minutes.
According to the USP, the friability test should not 
deviate NMT 1% [10].
5. Disintegration Test: This test is performed to check 
the time that a solid oral dosage form takes to
disintegrate completely. Disintegration means the 
breakdown of the tablet which refers to the quality of 
dosage form. As specified by the USP, uncoated tablets 
should disintegrate within 15 minutes. If 1 or 2 tablets fail 
to meet the given criteria then the test should be
repeated on the other 12 tablets, of which 16 out of 18 
should disintegrate in a given time. The disintegration 
test was performed using disintegration apparatus 
DS-0702 using water as the disintegration medium. 
Each tablet was placed in each of the six tubes of the 
basket. The tablets were monitored until they completely 
disintegrated.
6. Dissolution Test: It is the process by which dosage 
form becomes accessible for absorption which means 
the rate of drug absorption can be determined by drug 
dissolution.It is a useful tool to check in-vivo bioavailability 
and hence bioequivalence.
According to the USP, each tablet should dissolve
completely after 20 minutes at 50 rpm at 37oC. Tablet of 
each brand was placed in the vessel respectively.
The solution was withdrawn at different time intervals 
and absorbance was measured at 273 nm using UV 
spectrophotometer. The resultant absorbance of each 
tablet brand was then compared with the standard to 
obtain the percentage release of each brand.
Table 1: Brand Profile.
RESULTS AND DISCUSSION
The present study was performed to compare the differ-
ent commercially available brands of Glimepiride in 
Karachi, Pakistan. The brands were evaluated by the 
specified limits stated by the BP/USP.
Table 2 highlights the average weight, thickness, and 
hardness of the tablets of each brand. The average 
weight of each of the brands did not deviate from the 
pharmacopoeial specified limit i.e. 7.5%. Similarly, thick-
ness and hardness were found to also comply with the 
official pharmacopoeial limits.
The disintegration time of brands 1, 2, and 3 was found 
to be 21 sec, 10 sec, and 22 sec respectively. Also, all 
the tablets were completely dissolved within 20 minutes 
with more than 80% of the drug being released. Table 3 
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The statistical analysis of the results of the
physicochemical tests revealed minor variations in each 
of the brands. It was found that Getryl showed the
highest % dissolution among all the 3 brands whereas 
Amaryl took the least time to disintegrate. According
to the results of the friability test, Diabold shows the 
highest stability in the friabilator. By comparing the 
cost-effectiveness we found that Amaryl had the highest 
in price whereas Diabold was the most cost effective.
The results of our study were similar to the study 
conducted by Kassahan, where different brands of 
glibenclamide available in Ethiopia were evaluated
for their in-vitro quality. All the in-vitro quality control 
parameters were found to be within the official
pharmacopeial limits [11]. Another study also reported 
similar results where different brands of glibenclamide 
available in Saudi Arabia were compared [12].
CONCLUSION
Glimepiride is an effective anti-diabetic agent. The
quality of the drug largely influences its therapeutic 
activity. The brands under study were found to comply 
with the official limits and hence, concluded the brands 
can be interchangeably used. 
LIMITATION OF THE STUDY
The study had been performed only on 3 different brands 
of the Glimepiride. Increasing the number of brands will 
provide more options that can be interchangeably used 
with quality at the same time. 
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